Clinical Trials for KZR-616
KZR-616 is currently being evaluated in Phase 2 clinical trials for the treatment of lupus nephritis and dermatomyositis/polymyositis. Find out how KZR-616 works to harmonize the immune system.
Recruiting
A Phase 1b/2 Study of KZR-616 in Patients With Systemic Lupus Erythematosus with and without Nephritis
More Information